Cargando…

Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073

Detalles Bibliográficos
Autores principales: Greenbaum, Carla J., Beam, Craig A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661623/
https://www.ncbi.nlm.nih.gov/pubmed/23704535
http://dx.doi.org/10.2337/db13-0115
_version_ 1782270715370668032
author Greenbaum, Carla J.
Beam, Craig A.
author_facet Greenbaum, Carla J.
Beam, Craig A.
author_sort Greenbaum, Carla J.
collection PubMed
description
format Online
Article
Text
id pubmed-3661623
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36616232014-06-01 Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073 Greenbaum, Carla J. Beam, Craig A. Diabetes Online Letters to the Editor American Diabetes Association 2013-06 2013-05-17 /pmc/articles/PMC3661623/ /pubmed/23704535 http://dx.doi.org/10.2337/db13-0115 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters to the Editor
Greenbaum, Carla J.
Beam, Craig A.
Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
title Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
title_full Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
title_fullStr Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
title_full_unstemmed Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
title_short Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
title_sort response to comment on: greenbaum et al. fall in c-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite type 1 diabetes trialnet data. diabetes 2012;61:2066–2073
topic Online Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661623/
https://www.ncbi.nlm.nih.gov/pubmed/23704535
http://dx.doi.org/10.2337/db13-0115
work_keys_str_mv AT greenbaumcarlaj responsetocommentongreenbaumetalfallincpeptideduringfirst2yearsfromdiagnosisevidenceofatleasttwodistinctphasesfromcompositetype1diabetestrialnetdatadiabetes20126120662073
AT beamcraiga responsetocommentongreenbaumetalfallincpeptideduringfirst2yearsfromdiagnosisevidenceofatleasttwodistinctphasesfromcompositetype1diabetestrialnetdatadiabetes20126120662073
AT responsetocommentongreenbaumetalfallincpeptideduringfirst2yearsfromdiagnosisevidenceofatleasttwodistinctphasesfromcompositetype1diabetestrialnetdatadiabetes20126120662073